Highlights
• This partnership agreement brings together United Therapeutics' regenerative medicine and organ manufacturing capabilities and CollPlant's proprietary recombinant human collagen (rhCollagen) and BioInk technology
• The US-based firm has paid $3 million to CollPlant in order to exercise an option to license, on an executive basis, the Israeli technology for 3D bullfighting of human kidneys
....Tags : Kidney transplant, 3D Kidneys, United Therapeutics, CollPlant, ,
comments (0)